Learn about SPRAVATO® (esketamine) CIII nasal spray, a prescription medicine for two indications. See full Prescribing & Safety Info, including BOXED WARNINGS.

Learn about SPRAVATO® (esketamine) CIII nasal spray, a prescription medicine for two indications. See full Prescribing & Safety Info, including BOXED WARNINGS.

Learn about SPRAVATO® (esketamine) CIII nasal spray, a prescription medicine for two indications. See full Prescribing & Safety Info, including BOXED WARNINGS.

Learn about SPRAVATO® (esketamine) CIII nasal spray, a prescription medicine for two indications. See full Prescribing & Safety Info, including BOXED WARNINGS.

Learn about SPRAVATO® (esketamine) CIII nasal spray, a prescription medicine for two indications. See full Prescribing & Safety Info, including BOXED WARNINGS.

Learn about SPRAVATO® (esketamine) CIII nasal spray, a prescription medicine for two indications. See full Prescribing & Safety Info, including BOXED WARNINGS.

SPRAVATO® is an FDA-approved nasal spray for treatment-resistant depression; it is also approved to treat depressive symptoms in adults with major depressive disorder with suicidal thoughts or actions. Ketamine has not been approved by the FDA to treat depression.

Learn how to use SPRAVATO® (esketamine) nasal spray, including instructions for use (IFU) and dosing. See full Prescribing & Safety Info, including BOXED WARNINGS.

What is SPRAVATO® (esketamine) CIII nasal spray? SPRAVATO® is a prescription medicine, used along with an antidepressant taken by mouth to treat: • Adults with treatment-resistant depression (TRD) • Depressive symptoms in adults with major depressive disorder (MDD) with suicidal thoughts or actions

SPRAVATO® (esketamine) nasal spray, CIII Initial U.S. Approval: 1970 (ketamine) WARNING: SEDATION; DISSOCIATION; RESPIRATORY DEPRESSION; ABUSE AND MISUSE; and SUICIDAL THOUGHTS AND BEHAVIORS See full prescribing information for complete boxed warning. • Nasal Spray:Risk for sedation, dissociation, and respiratory depression after …